These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 30254643)

  • 1. TFPI-2 Protects Against Gram-Negative Bacterial Infection.
    Ali MN; Kasetty G; Elvén M; Alyafei S; Jovic S; Egesten A; Herwald H; Schmidtchen A; Papareddy P
    Front Immunol; 2018; 9():2072. PubMed ID: 30254643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vertebrate TFPI-2 C-terminal peptides exert therapeutic applications against Gram-negative infections.
    Kasetty G; Smeds E; Holmberg E; Wrange L; Adikesavan S; Papareddy P
    BMC Microbiol; 2016 Jun; 16(1):129. PubMed ID: 27349742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The TFPI-2 derived peptide EDC34 improves outcome of gram-negative sepsis.
    Papareddy P; Kalle M; Sørensen OE; Malmsten M; Mörgelin M; Schmidtchen A
    PLoS Pathog; 2013; 9(12):e1003803. PubMed ID: 24339780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue factor pathway inhibitor 2 is found in skin and its C-terminal region encodes for antibacterial activity.
    Papareddy P; Kalle M; Sørensen OE; Lundqvist K; Mörgelin M; Malmsten M; Schmidtchen A
    PLoS One; 2012; 7(12):e52772. PubMed ID: 23300768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-terminal peptides of tissue factor pathway inhibitor are novel host defense molecules.
    Papareddy P; Kalle M; Kasetty G; Mörgelin M; Rydengård V; Albiger B; Lundqvist K; Malmsten M; Schmidtchen A
    J Biol Chem; 2010 Sep; 285(36):28387-98. PubMed ID: 20592020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fragmented tissue factor pathway inhibitor (TFPI) and TFPI C-terminal peptides eliminate serum-resistant Escherichia coli from blood cultures.
    Schirm S; Liu X; Jennings LL; Jedrzejewski P; Dai Y; Hardy S
    J Infect Dis; 2009 Jun; 199(12):1807-15. PubMed ID: 19456231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced survival in Pseudomonas aeruginosa septicemia associated with high levels of circulating antibody to Escherichia coli endotoxin core.
    Pollack M; Huang AI; Prescott RK; Young LS; Hunter KW; Cruess DF; Tsai CM
    J Clin Invest; 1983 Dec; 72(6):1874-81. PubMed ID: 6358257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-PcrV antibody strategies against virulent Pseudomonas aeruginosa.
    Sawa T; Ito E; Nguyen VH; Haight M
    Hum Vaccin Immunother; 2014; 10(10):2843-52. PubMed ID: 25483637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization with outer membrane proteins (OprF and OprI) and flagellin B protects mice from pulmonary infection with mucoid and nonmucoid Pseudomonas aeruginosa.
    Hassan R; El-Naggar W; Abd El-Aziz AM; Shaaban M; Kenawy HI; Ali YM
    J Microbiol Immunol Infect; 2018 Jun; 51(3):312-320. PubMed ID: 28291719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL17-Producing γδ T Cells May Enhance Humoral Immunity during Pulmonary
    Pan T; Tan R; Li M; Liu Z; Wang X; Tian L; Liu J; Qu H
    Front Cell Infect Microbiol; 2016; 6():170. PubMed ID: 27999768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TC38, a teleost TFPI-2 peptide that kills bacteria via penetration of the cell membrane and interaction with nucleic acids.
    Zhang M; Yue B; Zhang AH; Wang GH; Liu Y; Zhou S; Cheng SF; Li NQ
    Fish Shellfish Immunol; 2017 May; 64():104-110. PubMed ID: 28263880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunization with the ferric iron-binding periplasmic protein HitA provides protection against Pseudomonas aeruginosa in the murine infection model.
    Elhosary MA; Bahey-El-Din M; AbdelBary A; El Guink N; Aboushleib HM
    Microb Pathog; 2019 Jun; 131():181-185. PubMed ID: 30978430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A teleost TFPI-2 peptide that possesses a broad antibacterial spectrum and immune-stimulatory properties.
    He SW; Wang JJ; Du X; Yue B; Wang GH; Zhou S; Xie B; Zhang M
    Fish Shellfish Immunol; 2018 Nov; 82():469-475. PubMed ID: 30149134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skin-Derived C-Terminal Filaggrin-2 Fragments Are Pseudomonas aeruginosa-Directed Antimicrobials Targeting Bacterial Replication.
    Hansmann B; Schröder JM; Gerstel U
    PLoS Pathog; 2015 Sep; 11(9):e1005159. PubMed ID: 26371476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibacterial Properties of Tebipenem Pivoxil Tablet, a New Oral Carbapenem Preparation against a Variety of Pathogenic Bacteria in Vitro and in Vivo.
    Yao Q; Wang J; Cui T; Yang Z; Su M; Zhao P; Yan H; Zhan Y; Yang H
    Molecules; 2016 Jan; 21(1):62. PubMed ID: 26751436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthetic Immunotherapeutics against Gram-negative Pathogens.
    Feigman MS; Kim S; Pidgeon SE; Yu Y; Ongwae GM; Patel DS; Regen S; Im W; Pires MM
    Cell Chem Biol; 2018 Oct; 25(10):1185-1194.e5. PubMed ID: 29983273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A TFPI-1 peptide that induces degradation of bacterial nucleic acids, and inhibits bacterial and viral infection in half-smooth tongue sole, Cynoglossus semilaevis.
    He SW; Zhang J; Li NQ; Zhou S; Yue B; Zhang M
    Fish Shellfish Immunol; 2017 Jan; 60():466-473. PubMed ID: 27840169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nebulized Recombinant Human Tissue Factor Pathway Inhibitor Attenuates Coagulation and Exerts Modest Anti-inflammatory Effects in Rat Models of Lung Injury.
    van den Boogaard FE; Hofstra JJ; Brands X; Levi MM; Roelofs JJ; Zaat SA; Van't Veer C; van der Poll T; Schultz MJ
    J Aerosol Med Pulm Drug Deliv; 2017 Apr; 30(2):91-99. PubMed ID: 27977318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxidasin contributes to lung host defense by direct binding and killing of gram-negative bacteria.
    Shi R; Cao Z; Li H; Graw J; Zhang G; Thannickal VJ; Cheng G
    PLoS Pathog; 2018 May; 14(5):e1007026. PubMed ID: 29775486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A noncovalent complex vaccine prepared with detoxified Escherichia coli J5 (Rc chemotype) lipopolysaccharide and Neisseria meningitidis Group B outer membrane protein produces protective antibodies against gram-negative bacteremia.
    Bhattacharjee AK; Opal SM; Taylor R; Naso R; Semenuk M; Zollinger WD; Moran EE; Young L; Hammack C; Sadoff JC; Cross AS
    J Infect Dis; 1996 May; 173(5):1157-63. PubMed ID: 8627067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.